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The mechanism of catalase loading into porous
vaterite CaCO3 crystals by co-synthesis†
A. S. Vikulina, *a N. A. Feoktistova,bc N. G. Balabushevich,b A. G. Skirtachd and
D. Volodkinab
Porous vaterite CaCO3 crystals are nowadays extensively used as high-capacity bio-friendly sacrificial
templates for the fabrication of such protein-containing nano- and micro-particles as capsules and
beads. The first step in the protein encapsulation is performed through loading of the protein molecules
into the crystals. Co-synthesis is one of the most useful and simple methods proven to eﬀectively load
crystals with proteins; however, the loading mechanism is still unknown. To understand the mechanism,
in this study, we focus on the loading of a model protein catalase into the crystals by means of
adsorption into pre-formed crystals (ADS) and co-synthesis (COS). Analysis of the physico-chemical
characteristics of the protein in solution and during the loading and simulation of the protein packing
into the crystals are performed. COS provides more eﬀective loading than ADS giving protein contents
in the crystals of 20.3 and 3.5 w/w%, respectively. Extremely high loading for COS providing a local
protein concentration of about 550 mg mL1 is explained by intermolecular protein interactions, i.e.
formation of protein aggregates induced by CaCl2 during the co-synthesis. This is supported by a lower
equilibrium constant obtained for COS (5  105 M1) than for ADS (23  105 M1), indicating a higher
aﬃnity of single protein molecules rather than aggregates to the crystal surface. Fitting the adsorption
isotherms by classical adsorption models has shown that the Langmuir and BET models describe the
adsorption phenomenon better than the Freundlich model, proving the aggregation in solution followed
by adsorption of the aggregates into the crystals. We believe that this study will be useful for protein
encapsulation through CaCO3 crystals using the COS method.
Introduction
Novel approaches for protein encapsulation are nowadays of
crucial importance because of an increased number of eﬀective
therapeutic proteins available on the market.1 Protein encapsu-
lation into micro- and nano-particles gives an option to protect
protein molecules against enzymatic cleavage (biodegradation)
and other external undesirable factors such as complexation
with bioactive compounds blocking the protein activity or local
pH changes. At the same time, the well-defined size and shape of
the protein particles allows the choice of a proper delivery route,
eﬀectively delivering the protein molecules to a target, and
releasing the protein in a controlled fashion.2,3 Scientific atten-
tion has focused on the development of novel approaches to
encapsulate proteins under mild conditions in order to prevent
any reduction of the protein bioactivity during the encapsulation
process, which is often hard to avoid using traditional encapsu-
lation technologies that employ mechanical stress, high or low
temperature, organic solvents, and surfactants.
One of the most eﬀective modern approaches is to encapsu-
late protein molecules into polymer-based microcapsules by
means of layer-by-layer polymer adsorption onto decomposable
cores followed by the core removal and formation of a multi-
layer capsule.4 The permeability of the multilayer capsule shell,
defined by the number of layers and the nature of the polymers
used, can be adjusted to provide a desired release rate of the
encapsulated protein.5–12 Studies of the multilayer structure
and the physico-chemical properties including permeability
may help to tune the release rate.13–15 Such multilayer capsules
have found a number of attractive biological applications in
drug delivery, tissue engineering, etc.8,10,11,16–19 Many kinds of
sacrificial cores have been used since then including melamine
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formaldehyde and polystyrene latex particles, silica particles,
poly(lactide-co-glycolide) particles, inorganic crystals such as
CaCO3, MnCO3, and CdCO3 and even erythrocytes.
20,21 Nowadays,
vaterite CaCO3 crystals
22–24 (vaterite is a crystalline polymorph
form of CaCO3) are most probably the most useful sacrificial
template because of a number of advantageous characteristics
over other decomposable cores that include: (i) highly devel-
oped surface areas due to porosity, (ii) bio-friendly decomposi-
tion conditions (slightly acidic pH, EDTA, or citric acid), and
(iii) easy to prepare in a lab from non-expensive precursor salts
such as Na2CO3 and CaCl2. It is of note that the mesoporous
structure of the crystals is very attractive for loading of bio-
macromolecules such as proteins that have sizes in the range of
a few of nm, thus giving an option to effectively fill the internal
volume of the CaCO3 crystal with pore sizes in the range of
tens of nm.
The crystals are made of nanocrystallites aggregated to each
other forming the crystal secondary structure. Control over the
crystal growth provides one with a simple way to adjust the
crystal porosity even without any additives.25,26 The surface of
the nanocrystallites can be coated with diﬀerent materials, for
example, lipids, for protection.27 Some recent eﬀorts have been
made in the size reduction of calcium carbonate crystals that
open new perspectives to employ the crystals for a wide range of
administration routes in modern drug delivery.27–33
The utilization of vaterite CaCO3 crystals for the formulation
of multilayer capsules has stimulated the employment of the
crystals to make new delivery vehicles for the encapsulation/
release of drugs and proteins. The pure crystals can be utilized
themselves or they can be used as templates to assemble func-
tional structures with encapsulated proteins34–39 as well as
various hydrophilic and hydrophobic drugs.17,33,40–44 Biologically
relevant particles assembled using the crystals can be made of
pure proteins45–48 or biologically relevant molecules such as
polyethylene glycol49,50 or temperature-sensitive polymers such
as poly(N-isopropylacrylamide).51 A number of bio-applications
have been reported utilizing the crystals as carriers for photo-
dynamic therapy,52–56 transcutaneous delivery,57 delivery into
the brain bypassing the blood–brain barrier,58 delivery of
insulin59,60 and vaccines,61,62 and as carriers in alternative
fields such as food industry.26 Crystal modification with nano-
particles allows external manipulation of the crystals63,64 that
can then be utilized for targeted delivery. Besides this, the high
loading capacity of CaCO3 crystals provides an opportunity for
slow long-term controlled release, which is of high interest for
therapeutic applications.65,66 A high content of the loaded
protein would give an option to reduce the number of carriers
for protein delivery (the crystals or other carriers assembled
using the crystal, e.g. microcapsules). This issue is especially
important for minimizing potential side effects, which may occur
due to the presence of the carriers. A high loading of proteins into
the crystals will also ensure a high loading capacity for the
carriers assembled using the crystal. We note that other applica-
tions of the crystals including sensors67,68 or self-assembled
tailor-made polymer macrostructures such as scaffolds69–71 have
been reported.
Protein can eﬀectively be loaded into the crystals using the
co-synthesis approach developed a decade ago.22,72,73 It is based
on trapping the protein molecules during the crystal growth
simply by adding the protein to the precursor salts used to
synthesize the crystals. This gives a very high eﬃciency of the
loading, high protein content, and uniform distribution of the
loaded protein molecules.74,75 A number of various proteins
such as aprotinin and insulin have been successfully loaded
into crystals by ADS and COS.74,75 The morphology of the crystals
may aﬀect the protein loading,76 which is of high importance for
pharmacological applications.77
Although the potential for the utilization of crystals as
carriers for protein loading is obvious, the loading mechanism
through co-synthesis is poorly understood. Our recent works
demonstrated some new findings on the interaction between
protein molecules and crystals; however, the loading mecha-
nism is still unknown. To our knowledge, there is no explana-
tion for how the crystals can host such extremely large amounts
of protein of about 10% by mass or more giving an estimated
protein concentration in the crystals so high that it may not
be possible to reach in solution at all. Nevertheless, recent
reports indicate that the loading mechanism is tightly related
to the ionic interactions between proteins and particles
making the encapsulation of proteins highly dependent on
the pH of reaction solutions and the isoelectric point of the
protein.78,79
In this study, we focus on understanding the mechanism of
protein loading into the CaCO3 crystals by co-synthesis. For this
purpose, we analysed the loading into pre-formed crystals
(adsorption, ADS) and the loading by co-synthesis (COS) using
catalase as a model protein and employing classical adsorption
theories. Analysis of the crystal internal structure and physico-
chemical properties of the protein in solution and simulation
of the protein loading are performed.
Experimental
Materials
Calcium chloride dihydrate CaCl22H2O (Sigma-Aldrich, Japan);
sodium carbonate Na2CO3 anhydrous (Sigma-Aldrich, Germany);
catalase from bovine liver – 3809 units per mg solid (Sigma,
Germany (C-1345)); 0.05 M glycine buffer (pH 9.0), 0.05 M
phosphate buffer (pH 7.0), ethylenediamine-tetraacetic acid
(EDTA) and hydrogen peroxide were purchased from Sigma,
USA; water used in all experiments was prepared via a Millipore
Milli-Q purification system and had a resistivity higher than
18.2 MO cm.
Preparation of CaCO3 crystals
Porous crystals were prepared by rapid mixing of equal volumes
of CaCl2 and Na2CO3 aqueous solutions at 22 1C. Briefly, 3 mL
of 1 M CaCl2 was added to 9 mL of H2O at constant stirring,
then 3 mL of 1 M Na2CO3 was rapidly added to the solution at
22 1C. After vigorous agitation with a magnetic stirrer for 40 s
and incubation for 15 min, the suspension was thoroughly
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washed with pure water and dried at 80 1C producing crystals
with the size of 4–5 mm.
Protein loading into CaCO3 crystals by ADS
1.5 mL of catalase solution (0.1–2 mg mL1) in 0.05 M glycine
buffer, pH 9.0, was added to 60 mg of the dried CaCO3 crystals
and incubated for 30 min followed by centrifugation for 5 min at
1000g. Then, the solution was rinsed twice and all the super-
natants were collected and examined to determine the protein
concentration by using UV spectroscopy at 280 nm (Lambda 35,
‘‘Perkin-Elmer’’, UK) (Fig. S1, ESI†).
Protein loading into CaCO3 crystals by COS
0.2 mL of 1 M CaCl2 was added to 0.6 mL of protein solution at
a constant stirring rate, then 0.2 mL of 1 M Na2CO3 was rapidly
added to the solution at 22 1C. After vigorous agitation with
a magnetic stirrer for 40 s and incubation for 15 min, the
suspension was thoroughly washed two or three times with
0.05 M glycine buﬀer, pH 9.0, and all the supernatants were
collected and examined to determine the protein concentration
using UV spectroscopy at 280 nm.
Field emission scanning electron microscopy (SEM)
SEM images were recorded using a Gemini LEO 1550 electron
microscope at an accelerating voltage of 3 kV. The samples were
prepared by dropping the crystal suspension on a glass slide,
which was dried for 1 h at 90 1C followed by conductive coating
with gold palladium (5 nm).
Brunauer, Emmett, and Teller (BET) analysis
Tomeasure the surface area of the prepared crystal, N2 adsorption–
desorption analysis was performed using a QUADRASORB SI-MP
(Quantachrome Instruments, USA) at 77.3 K. Prior tomeasurement,
the samples were degassed at 150 1C for 20 h. BET theory was used
for the surface area analysis.
Dynamic light scattering (DLS)
DLS measurements of the hydrodynamic diameter of the cata-
lase were performed with a Zetasizer Nano ZS (Malvern Instru-
ments Limited, Worcestershire, UK). For DLS measurements,
protein solution was freshly prepared in ultrapure water or a
corresponding solution. The concentration of protein in solution
was 0.2 mg mL1 and the protein was incubated in the corres-
ponding solutions for 1–2 h followed by filtration with a 0.22 mm
filter prior to measurement.
Catalase specific activity
The specific activity of catalase was measured bymonitoring the rate
of hydrogen peroxide decomposition. A mixture of 0.040–0.100 mL
of the enzyme solution containing 0.005–0.010 mg mL1 catalase,
0.800–0.860 mL of 0.1 M phosphate buffer (pH 7.0) and 0.100 mL of
0.196 M hydrogen peroxide in water was prepared. A decrease in
absorbance was registered at 240 nm. Retention of the catalase
activity was calculated as the ratio between the activity of the enzyme
recovered after crystal dissolution in 0.2 M EDTA and the activity of
the initial catalase in phosphate buffer, pH 7.0.
Results and discussion
Thermodynamics of catalase loading into the crystals
The model protein catalase was loaded into the CaCO3 crystals
either by ADS75 or COS. For the ADS method, the prepared
crystals were incubated in the catalase solution. The COS method
is based on the addition of catalase to the precursor salts used for
the crystal synthesis (sometimes called co-precipitation72). Fig. 1a
shows the content of catalase in the crystals as a function of the
initial catalase concentration used for the loading (c0) for the two
loading methods.
The amount of loaded protein under saturation conditions
(equilibrium) was calculated using the following equation:
qe ¼ c0  ceð Þ  V
m
(1)
where qe is the adsorption capacity (mg g
1), c0 and ce are
the initial and equilibrium protein concentrations, respectively
(mgmL1), V is the volume (mL) of the protein solution, andm is
the mass (g) of CaCO3.
Both the ADS and COS methods are manifested by a high
loading eﬃciency, which is close to 100% uptake from the
catalase solutions of low concentrations and linearly decreases
Fig. 1 (a) Concentration dependence of adsorption capacity and
(b) adsorption isotherms for protein loading by ADS (black circles) and
COS (gray circles). Standard deviations (SD) are given for n = 3. Experiments
are done in 0.05 M glycine buﬀer, pH 9.0.
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with the increase in the initial concentration of catalase due to
the saturation of the crystals (Fig. S2, ESI†).
Typically, the reversible interaction of molecules of interest
with a solid substrate is quantified using adsorption isotherms
by plotting the content of the adsorbed molecules in the sub-
strate against the equilibrium concentration of the molecules
(the concentration typically measured in the supernatant).
The isotherm reflects the aﬃnity of the molecules to the
substrate.
The thermodynamic parameters of the adsorption process
can be obtained from the isotherm. Fig. 1b shows the adsorp-
tion isotherms for catalase loading by means of ADS and COS.
The ADS method results in saturation of the crystals with
catalase at the protein equilibrium concentration of more than
B0.4 mg mL1. At the same time, the crystals loaded by COS
are not saturated with the protein, even at a higher equilibrium
concentration of 1 mg mL1, much above that needed for
saturation in the ADS method. The adsorption isotherms for
both protein loading methods are displayed in Fig. 2 showing
the clear trend towards saturation at the equilibrium concen-
tration of about 1 and 7 mg mL1 for ADS and COS, respectively.
In order to quantify the aﬃnity of catalase to the crystals,
three mathematical models generally accepted for the adsorp-
tion of proteins from a liquid phase to a solid phase have
been employed, namely the Langmuir, Freundlich, and Brunauer–
Emmett–Teller (BET) adsorption models.80,81 Eqn (2)–(4) are given
as follows for these models, respectively.
qe ¼ qmKace
1þ Kace (2)
qe = KFcne (3)
qe ¼ qmono  KSce
1 KLceð Þ  1þ KSce  KLceð Þ (4)
where qe is the equilibrium adsorption capacity (mg g
1), ce is
the equilibrium protein concentration (mg mL1), qm is the
maximum adsorption capacity (mg g1), Ka is the adsorption
equilibrium constant (mL mg1), KF is the Freundlich constant
(indicates the adsorption capacity), n is the constant of non-
linearity, qmono is the maximum capacity of the adsorption
monolayer (mg g1), KS is the adsorption equilibrium constant for
binding of the molecules in a strong adsorption site (mL mg1),
and KL is the adsorption equilibrium constant for the weak
adsorption site (mL mg1).
It is of note that the BET equation presented above is derived
from the common BET equation that was originally developed
for gas adsorption and was adopted for the adsorption of
liquids.82,83 This equation is based on the assumption that
the adsorbate molecule (protein) can be adsorbed either to the
surface of an adsorbent (first layer) or to another adsorbate
molecule (which is already anchored to the surface, the second
layer); adsorption to the first layer is thermodynamically more
favorable compared to adsorption to the second layer (KS4 KL).
In our case, the adsorption constant KS characterizes the binding
of catalase to the CaCO3 surface and KL is devoted to catalase
binding to another catalase molecule that is already adsorbed.
If not specified, hereinafter, the term surface will be used to
describe the overall surface of the porous vaterite CaCO3 crystals,
i.e. both the outer and inner surfaces.
The three models considered in this study describe diﬀerent
scenarios for the adsorption of catalase. The Langmuir model
can be employed for monolayer adsorption describing the
formation of only one layer of the protein on the CaCO3 surface.
The interactions between protein molecules are negligible,
meaning that the Langmuir model does not predict any inter-
protein interactions such as protein aggregation. It is also of
high importance that this model is based on statistical thermo-
dynamics and allows calculation of the adsorption equilibrium
constant. In contrast, the Freundlich model of monolayer adsorp-
tion has been developed empirically. The model is typically
employed for the first part of the adsorption isotherm and
describes the adsorption driven by attraction (n 4 1) or accom-
panied by repulsion (no 1) of proteinmolecules. Finally, the BET
model is based on an extension of the Langmuir model and it
describes the polyadsorption phenomenon.
The parameters extracted by the mathematical treatment
of the COS and ADS isotherms are summarized in Table 1.
Obviously, the Freundlich model does not provide a good fit
(R2 o 0.95) for the experimental adsorption isotherm. This
indicates independent adsorption of the catalase molecules,
Fig. 2 Adsorption isotherm for COS (a) and ADS (b) methods in a wide
range of protein concentrations and the fitting of the isotherms with
Langmuir, Freundlich and BET equations. For the experimental isotherms,
the error bars are SD for n = 3.
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which is not influenced by possible aggregation of catalase.
On the other hand, both the Langmuir and BET models are
characterized by high and close values of the coeﬃcient of
determination (R2 4 0.95). Notably, the value of the weak
adsorption state equilibrium constant (KL) calculated for the
BET model can be neglected compared to the high value of the
adsorption constant for proteins in the strong adsorption state
(KS c KL). This reduces eqn (4) to eqn (2) with KS = Ka and
qmono = qm and, as a result, allows the loading of catalase into
the CaCO3 crystals to be described by the Langmuir model.
This finding supports the idea that the protein loading by
both COS and ADS is driven by the high aﬃnity of the protein
to the CaCO3 crystals. The maximum adsorption capacity qm
reaches much higher values for COS than for ADS (qm of
203  5 and 35  2 mg g1, respectively). Thus, if one assumes
that the pure protein solution has a density of about 1 g cm3,
the maximal protein content in the crystals is 20.3 and 3.5 w/w%
for COS and ADS, respectively. Taking into account that the
density of CaCO3 is much higher than for water (2.7 g cm
3),24
the estimated concentration of the catalase inside the crystals
reaches values of about 550 and 95 mg mL1 for the COS and
ADS methods, respectively. The result, showing a high diﬀerence
in adsorption capacity for ADS and COS, corroborates well with
literature findings on the inclusion of other proteins (e.g. lyso-
zyme, chymotrypsin) into the crystals by these methods.72
Despite the fact that the COS method can provide much higher
protein loading than ADS, the aﬃnity of catalase to the crystal
surface is higher for the ADS method (Ka is 23 1  105 M1 for
ADS against 5  1  105 M1 for COS). The values of the Gibbs
free energy (DG) can be calculated from Ka giving the values of
36  2 and 32  7 kJ mol1 for ADS and COS, respectively.
These values indicate that the aﬃnity of the protein to the
crystals is higher for ADS compared to COS.
Modelling of catalase loading into the crystals
In order to further understand the mechanism of the protein
loading into the CaCO3 crystals, it is important to estimate the
theoretical adsorption capacity of the crystals and compare it
with the experimentally found values. Obviously, the surface
area of the crystals is the determinative factor influencing
the adsorption capacity. In this study, surface area has been
measured by nitrogen adsorption–desorption using the BET
approach.
It is known that the BET surface area and pore distribution
strongly depend on the amount of loaded protein.84 Because of
this reason, BET analysis was performed using the CaCO3
crystals synthesized in the absence of catalase. The very high
content of the protein in the crystals prepared by COS (qm of
203  5 mg g1) will not allow for an appropriate analysis of the
surface area and the porosity of the protein-loaded crystals. In
addition, it has recently been shown that glycine molecules
entrapped inside CaCO3 crystals during the synthesis
85 may
also interfere with the results of BET analysis. At the same time,
we compared the SEM images of the CaCO3 crystals grown in
water and in 0.05 M glycine buﬀer pH 9.0 and verified that their
structure was identical (Fig. S3a, b and d, ESI†). That is why the
BET analysis was performed for the crystals prepared in water.
A summary of the BET analysis is given in Table S1 (ESI†). The
crystals have a surface area of 10.4 m2 g1 and a pore diameter
in the range of 5 to 30 nm with a maximum of about 10 nm
(Fig. 3). The specific surface is similar to that reported for
crystals prepared under similar conditions.24
The protein loading into the crystals was evaluated using three
models for protein packing into the crystal pores (Fig. 4a–c).
Table 1 Mathematical fitting of adsorption isotherms (Fig. 2) by eqn (2)–(4) for catalase loading into CaCO3 crystals by ADS and COS
Model
Parameters Coeﬃcient of determination (R2)
ADS COS ADS COS
Langmuir qm = 35  2 mg g1 qm = 203  5 mg g1 0.987 0.969
Ka = (23  1)  105 M1 Ka = (5  1)  105 M1
Freundlich KF = 46  1 KF = 117  5 0.932 0.947
n = 0.5  0.1 n = 0.3  0.1
BET qmono = 30  3 mg g1 qmono = 206  4 mg g1 0.996 0.986
KS = (29  2)  105 M1 KS = (4.7  0.2)  105 M1
KL = (36  5)  103 M1 KL = 405  5 M1
Fig. 3 Diﬀerential pore volume distributions for 5 mm sized CaCO3
crystals determined by BET analysis using the Barret–Joyner–Halenda
(BJH) model (grey circles). The fitting of the experimental data with a
lognormal function (black curve) is given. Pure crystals are synthesized in
water at 22 1C.
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A detailed description of the models is given in Fig. S4 (ESI†).
The hydrodynamic diameter and molecular weight of a catalase
molecule were taken as 10.5 nm and 4.15 1019 g, respectively.
First, we assumed that the surface area of the CaCO3 crystals can
be packed with protein molecules in a 2D plane view (model A).
This assumption would mean that all the surfaces of the crystals
can be occupied by a monolayer of the protein molecules
(no steric limitations to diffuse into the pores, this model has
been used in our previous work75).
This results in a maximum adsorption capacity calculated as
40 mg of catalase per 1 g of the crystals. Model B assumes that
the pores of the crystals have a cylindrical shape with a
diameter of 10.5 nm that corresponds to the size of the protein.
This allows compact protein packing in the crystal pores. Model
B predicts a maximum adsorption capacity of 13 mg of catalase
per 1 g of the crystals. Finally, the third model C assumes that
the pores have a certain size distribution. The experimental
pore distribution for this model was constructed based on the
BET analysis (Fig. 3). It was fitted with a lognormal function
(R2 0.955), as is shown in Fig. 3. The pore diameter of 10.5 nm
was set up as a threshold for the catalase loading, meaning that
the catalase molecules cannot penetrate into the pores of
diameter o 10.5 nm (D1 in Fig. 4c). The pores of diameter
10.5–21.0 nm are closely packed with the protein molecules (Di in
Fig. 4c). The volume fraction of pores with diameter4 21 nm was
found to be less than 5% and was neglected. According to model
C, up to 2 mg of catalase per 1 g of the crystals can be loaded.
The first two models (A and B) provide presumably over-
estimated values for the protein adsorption (40 and 13 mg of
catalase per 1 g of the CaCO3 crystals) because compact packing
of protein molecules for full coverage of the crystal area being
planar or ideally cylindrical is hardly possible due to steric
limitations. Molecules of nitrogen used for the determination of
the surface area by the BET analysis are much smaller than those
of catalase and steric limitations are much less pronounced for
nitrogen. At the same time, model C takes into account steric
limitations and this model assumes that only pores larger than
the size of the protein molecule will be accessible for the protein.
Thus, the maximum capacity calculated based on model C seems
to be more realistic. At the same time, the experimentally found
maximum adsorption capacities for both the ADS and COS
methods exceed the theoretical values obtained for model C by
one to two orders of magnitude (Table 1). This may be explained
by the deviation from the cylindrical shape of the pores and the
formation of vessel-like enlargements in the pore structure. These
‘‘vessels’’ inside the crystals may host much higher amounts of
protein molecules. The non-uniform shape of the pore due to the
‘‘vessels’’ would allow many more protein molecules to be hosted
in the larger pores because the pore volume scales with the pore
size by three orders of magnitude. This would increase the
theoretically expected loading values and explain the very high
loading capacities of the crystals. For COS, the maximum loading
capacity is approximately six times higher than that for ADS
(Table 1).
A previous report clearly demonstrated that catalase is
distributed within the entire volume of CaCO3 crystals as well
as on the external surface of the crystals.75 This indicates that
such a high diﬀerence between adsorption capacities found for
ADS and COS loading is most likely not associated with the
impregnation of the external surface of the CaCO3 crystals. In
order to explain the high protein content in the crystals
prepared by COS, one can assume that two possible scenarios
may take place. One explanation might be related to a higher
porosity of the crystals formed by COS that will make the total
surface area of the crystals much larger. Another explanation
can be related to the formation of protein aggregates in the
pores. These two assumptions will be considered in the following
sections below.
Internal structure of CaCO3 crystals
CaCO3 crystals synthesized in water at room temperature using
a standard procedure24 yield rather monodispersed meso-
porous crystals. The SEM images (Fig. 5a and b) show the
typical morphology of the crystals and the highly developed
internal structure of a broken crystal. The crystal is formed due
to the secondary aggregation of spherical nanocrystallites
with sizes of a few tens of nm. The pores on the outer surface
of the crystals represent the space between the aggregated
spherical nanocrystallites, however, this does not provide infor-
mation about the internal structure of the crystal. If the crystal
is broken (Fig. 5b), the internal structure can be identified,
showing a channel-like structure. This is most probably due
to the growth mechanism of the crystals based on the stacking
of the nanocrystallites on top of each other. It is thus logical
to assume that the pores of the crystals have a channel-like
structure and may be described as cylinders, rather than
spheres.
Analysis of the crystal internal structure revealed that the
crystal porosity for empty (not loaded with protein) crystals is
similar to that for the crystals obtained by COS (Fig. S3, ESI†).
It is more likely that catalase loading by COS is associated with
protein aggregation, however, additional evidence is required.
In the sections below, we further examine the protein loading
processes in order to further assess our assumption.
Fig. 4 Schematic illustration of the three models (a–c) employed to estimate the theoretical maximum adsorption capacity of the CaCO3 crystals for
catalase. L, D and V are the length, diameter and volume of a cylindrical pore, respectively.
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Catalase colloidal stability during ADS and COS
The obvious diﬀerence between the loading methods is that
during the COS loading, catalase is exposed to the two pre-
cursor salts (CaCl2 and Na2CO3) used for the synthesis of the
crystals. For the ADS method, catalase is in contact with the
already synthetized crystals. Thus, we first tested if the presence
of the salts can aﬀect the colloidal stability of the protein in
solution.
Fig. 6 shows the DLS volume-weighted size distribution
for catalase in water and in the presence of the supernatant
of the crystals, as well as 0.2 M CaCl2 and 0.2 M Na2CO3 water
solutions.
The supernatant of the crystals does not aﬀect the colloidal
stability of the protein and only a small number of protein
aggregates was detected (Fig. 6b). The presence of 0.2 M Na2CO3
does not significantly aﬀect the colloidal stability either and
only a small peak of aggregates of about 40–50 nm can be
detected (Fig. 6c). Meanwhile, the presence of 0.2 M CaCl2
significantly reduces the colloidal stability and one cannot see the
peak corresponding to single catalase molecules (about 10 nm);
only large aggregates with average sizes of about 50 and 200 nm
can be found (Fig. 6d). One should note that the concentration of
the tested salts in the catalase solution was chosen to be the same
as during the protein loading by COS.
The DLS results clearly demonstrate that CaCl2 induces
catalase aggregation and this is most probably the reason that
the protein aggregates are trapped in the crystals during the
COS process, resulting in a very high loading of the protein into
the crystals by COS. This means that the crystals formed by COS
may have larger pores than the bare crystals in order to host
protein aggregates of sizes 50 and 200 nm that exceed the
average pore size of the bare crystals (about 10 nm). The number
of such large pores may be, however, much smaller than those of
a regular size because the capacity of the larger pores to host
protein molecules will significantly exceed that of the smaller
ones. This is true if the pores are completely filled by protein, as
expected in the case of trapping of the protein aggregates into
the pores during the COS. At the same time, the aggregation is
supposed to be a reversible process with an equilibrium in
formation of aggregates of various sizes. Therefore, the aggre-
gates of smaller sizes (below 50 nm) may be enriched during the
COS and trapped into the pores of regular sizes.
We suppose that the aggregation of protein molecules might
play a crucial role not only for catalase loading but also for a
number of other proteins for which intra- and intermolecular
interactions favour protein stability. These include, for instance,
insulin,86 immunoglobulin antibodies87 and other therapeutic
proteins.88 Besides this, the isoelectric point of the used protein
and the in-process and final pH of the formulation may have a
significant eﬀect on the protein–protein interaction. We are
considering these issues in our current research and hope that
our further studies will help to shed light on these questions.
In this study, the isoelectric point of catalase (5.4) is below the
pH value of the used buffer (pH 9.0) or pH in water solution of
the crystals (pH 10.2), which ensures the negative charge of the
protein.
The mechanism of catalase loading by the ADS and COS
methods
Fig. 7 shows the proposed mechanism of catalase loading based
on the findings described above. Evidently, Ca2+-induced aggre-
gation of catalase plays a crucial role in the protein loading into
the crystals by COS, which is consistent with the influence of
gelatin.33 The rather high concentration of Ca2+ (on the order of
101 M) needed for the COS procedure results in the formation
of catalase aggregates. The loading by ADS seems also to include
a small number of aggregates formed in the presence of a rather
low concentration of Ca2+ (about 105 M) in the supernatant of
the crystals due to the dissociation of CaCO3 (Fig. 6b). However,
the fact that adsorption isotherms constructed for both COS
and ADS methods obey the Langmuir equation means that the
Fig. 5 SEM images of CaCO3 crystals. Scale bar is 2 mm for (a) and 1 mm
for (b). The inset shows the internal structure of the broken crystal
(enlarged 2 times).
Fig. 6 Volumeweighted DLS size distribution of catalase in water solution (a),
in the presence of the supernatant of the CaCo3 crystals (b), and in 0.2Mwater
solutions of Na2Co3 (c) and CaCl2 (d).
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aggregation has no eﬀect on the isotherm shape. This suggests
that the aggregates are predominantly formed in the solution
and then adsorbed onto the surface of the CaCO3 crystals. This
is supported by the fact that for the COS method, the protein is
first dissolved in the solution of CaCl2 followed by the addition
of Na2CO3. Formation of the protein aggregates on the surface
of the CaCO3 crystals by consequent growth of the aggregates
on the surface is not likely. It is also important to note that
since Ka for COS (5  105 M1) is lower than that for ADS
(23  105 M1), the aﬃnity of the protein aggregates to the
CaCO3 crystals is assumed to be lower than that for single
protein molecules. This is logical because the aggregate is large
and may not be ideally spherical, resulting in a less defined
contact area for adsorption to the crystal surface.
The aggregated state of the protein loaded by COS may
dramatically aﬀect the structure and the properties of the protein.
It is known that catalase retains around 79% of its specific
activity after loading into CaCO3 crystals by ADS.
74 Here, we have
tested the retention of catalase activity after loading into CaCO3
crystals by COS using a similar approach. Taking into account the
maximum adsorption capacities found in this study, it was found
that the maximum amount of active protein (after dissolution of
the core with EDTA) for COS is 60.9 mg per 1 g of CaCO3 crystals
while encapsulation by ADS from a solution of the same protein
concentration provides 27.7 mg of active catalase per 1 g of
CaCO3 crystals. These preliminary data indicate the high
potential of the COS approach for loading large amounts of
active protein. A more detailed study on the retention of catalase
enzymatic activity is a focus for our upcoming study.
The stability of the aggregates entrapped in the CaCO3
crystals was tested by intensive washing of the crystals with
0.05 M glycine buﬀer pH 9.0 (Fig. S5, ESI†). It was revealed that
catalase loaded by COS cannot be eﬀectively washed out by a
single washing step while catalase loaded by the ADS method is
not retained in the crystals and even a single washing leads to
the release of the catalase. These data support the proposed
mechanism of catalase inclusion into the CaCO3 crystals by
passive and active loading.
Besides this, the eﬀectiveness of protein release as well as
the influence of crystal preparation conditions (salt concen-
tration, preparation temperature, crystallization time, etc.) on
both loading and release eﬃciency should be tested for a better
understanding of the mechanism of catalase loading. These
issues will be further investigated in upcoming studies.
Conclusions
Catalase can be eﬀectively loaded into vaterite CaCO3 crystals
through ADS or COS methods. The loading capacity is very high
for both methods (35  2 and 203  5 mg of the protein per 1 g of
the crystals). This exceeds the amount required for the formation of
a compact monolayer. Most likely, the monolayer is rather impos-
sible due to the similar size of the protein and the average pore size
(both about 10 nm). Such a high loading can be explained by non-
homogeneous channel-like pores with ‘‘vessels’’ where protein
molecules in large numbers can be hosted. Protein aggregates of
typical sizes 50 and 200 nm are formed due to the presence of Ca2+
and are present for both methods. Rather a small concentration of
Ca2+ of about 105 M due to the dissociation of CaCO3 during ADS
gives a small number of aggregates andmostly adsorption of single
protein molecules occurs. At the same time, the COS method
requires a much higher Ca2+ concentration on the order of
101 M that results in a dominating presence of aggregates during
COS. Since the isotherms of protein adsorption for both loading
methods obey the Langmuir equation, the protein aggregation has
no eﬀect on the isotherm shape, proving that the aggregates are
predominantly formed in the solution and then adsorbed onto the
CaCO3 crystal surface. A higher aﬃnity of catalase to the crystal
surface in the case of ADS (Ka = 23  105 M1) compared to that of
COS (Ka = 5  105 M1) also proves this assumption.
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